In Nov. 2022, the U.S. nonprofit Multidisciplinary Affiliation for Psychedelic Studies (MAPS) introduced that it experienced done a next phase-three demo on MDMA being a treatment for PTSD—a stage broadly noticed as the final hurdle to distinct prior to making use of for acceptance in the U.S. foods